Immunization, HepB3 in Europe & Central Asia (IDA & IBRD countries)
Europe & Central Asia (IDA & IBRD countries): Immunization, HepB3 was 92.7% in 2024. ◆ Volatile
Immunization, HepB3 in Europe & Central Asia (IDA & IBRD countries), 1992–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
In 2024, immunization, hepb3 in Europe & Central Asia (IDA & IBRD countries) stood at 92.7%.
The figure is down 1.6% on the previous year and up 3.1% over ten years.
Over the whole period, immunization, hepb3 in Europe & Central Asia (IDA & IBRD countries) peaked at 95.1% in 2007 and was at its lowest, 1.0%, in 1992.
Europe & Central Asia (IDA & IBRD countries) ranks 4th of 47 groups on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Europe & Central Asia (IDA & IBRD countries), year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1992 | 1.0% | — |
| 1993 | 1.3% | +29.2% |
| 1994 | 2.6% | +93.9% |
| 1995 | 4.1% | +59.9% |
| 1996 | 11.0% | +170.2% |
| 1997 | 13.7% | +24.7% |
| 1998 | 16.3% | +18.9% |
| 1999 | 18.2% | +11.2% |
| 2000 | 39.2% | +115.5% |
| 2001 | 51.4% | +31.2% |
| 2002 | 73.6% | +43.2% |
| 2003 | 81.5% | +10.7% |
| 2004 | 89.0% | +9.2% |
| 2005 | 91.3% | +2.6% |
| 2006 | 91.5% | +0.2% |
| 2007 | 95.1% | +4.0% |
| 2008 | 93.4% | -1.8% |
| 2009 | 93.0% | -0.3% |
| 2010 | 92.4% | -0.7% |
| 2011 | 90.3% | -2.2% |
| 2012 | 92.2% | +2.0% |
| 2013 | 92.3% | +0.2% |
| 2014 | 90.0% | -2.6% |
| 2015 | 90.6% | +0.7% |
| 2016 | 90.5% | -0.1% |
| 2017 | 92.8% | +2.6% |
| 2018 | 94.0% | +1.3% |
| 2019 | 94.7% | +0.7% |
| 2020 | 93.0% | -1.8% |
| 2021 | 92.9% | -0.1% |
| 2022 | 93.6% | +0.7% |
| 2023 | 94.2% | +0.7% |
| 2024 | 92.7% | -1.6% |
Biggest year-on-year movements
Years where Immunization, HepB3 in Europe & Central Asia (IDA & IBRD countries) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1996 | +170.2% | 4.1% | 11.0% |
| 2000 | +115.5% | 18.2% | 39.2% |
| 1994 | +93.9% | 1.3% | 2.6% |
| 1995 | +59.9% | 2.6% | 4.1% |
| 2002 | +43.2% | 51.4% | 73.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 8.5% | 1.0% | 18.2% | 8 |
| 2000s | 79.9% | 39.2% | 95.1% | 10 |
| 2010s | 92.0% | 90.0% | 94.7% | 10 |
| 2020s | 93.3% | 92.7% | 94.2% | 5 |
Countries ranked near Europe & Central Asia (IDA & IBRD countries)
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei Darussalam 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Korea, Democratic People's Republic of 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Latvia 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Oman 99.0% compare
- 1 Palau 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Türkiye 99.0% compare
- 1 Turkmenistan 99.0% compare
More health data for Europe & Central Asia (IDA & IBRD countries)
- Population ages 30-34, male, per capita 0.035 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0402 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -0.0639 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0397 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1882 % change on previous year (2025)
- Population ages 25-29, male, per capita 0.0307 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Europe & Central Asia (IDA & IBRD countries)?
- Immunization, hepb3 in Europe & Central Asia (IDA & IBRD countries) was 92.7% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Europe & Central Asia (IDA & IBRD countries)?
- The highest recorded value was 95.1% in 2007.
- What is the lowest immunization, hepb3 recorded in Europe & Central Asia (IDA & IBRD countries)?
- The lowest recorded value was 1.0% in 1992.
- How does Europe & Central Asia (IDA & IBRD countries) rank for immunization, hepb3?
- Europe & Central Asia (IDA & IBRD countries) ranks 4th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Europe & Central Asia (IDA & IBRD countries)?
- Over the last ten years it is up 3.1%. The long-run trend across the full record is volatile.
- Where does this Europe & Central Asia (IDA & IBRD countries) data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.